BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 7843256)

  • 1. Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes.
    Hansson J; Dohlsten M; Sjögren HO; Hedlund G
    Eur J Immunol; 1995 Jan; 25(1):75-9. PubMed ID: 7843256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
    Hansson J; Ericsson PO; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
    Int Immunol; 1994 Sep; 6(9):1375-81. PubMed ID: 7819146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
    Yrlid U; Petersson E; Dohlsten M; Hedlund G
    Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity.
    Ericsson PO; Hansson J; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
    Eur J Immunol; 1991 Nov; 21(11):2797-802. PubMed ID: 1718760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells.
    Okumura C; Suto R; Furukawa K; Ahmed SS; Furukawa K; Nakayama E; Fujii T; Shiku H
    J Immunol; 1995 Feb; 154(3):1114-23. PubMed ID: 7822788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD3 delta in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3 delta-negative cytotoxic T lymphocyte variant.
    Buferne M; Luton F; Letourneur F; Hoeveler A; Couez D; Barad M; Malissen B; Schmitt-Verhulst AM; Boyer C
    J Immunol; 1992 Feb; 148(3):657-64. PubMed ID: 1530953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 alternative exon expression in murine and human CD4+ T cell subsets.
    Rogers PR; Pilapil S; Hayakawa K; Romain PL; Parker DC
    J Immunol; 1992 Jun; 148(12):4054-65. PubMed ID: 1351092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of rat T cell subpopulations expressing T cell receptors alpha/beta and gamma/delta.
    Lawetzky A; Tiefenthaler G; Kubo R; Hünig T
    Eur J Immunol; 1990 Feb; 20(2):343-9. PubMed ID: 2138084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of CD3+ (T cell receptor alpha/beta or gamma/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood.
    Jarry A; Cerf-Bensussan N; Brousse N; Selz F; Guy-Grand D
    Eur J Immunol; 1990 May; 20(5):1097-103. PubMed ID: 2141568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
    Zapata JM; Pulido R; Acevedo A; Sánchez-Madrid F; de Landázuri MO
    J Immunol; 1994 Apr; 152(8):3852-61. PubMed ID: 8144955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
    Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
    J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD11a and CD45R isoforms defines distinct subsets of CD8+ TCR alpha beta and TCR gamma delta CTL in vivo.
    Hedlund G; Hansson J; Ericsson PO; Sjögren HO; Dohlsten M
    Immunol Rev; 1995 Aug; 146():82-94. PubMed ID: 7493762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice.
    Kong YY; Kishihara K; Yoshida H; Mak TW; Nomoto K
    J Immunol; 1995 Jun; 154(11):5725-35. PubMed ID: 7751624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.
    Scott CS; Richards SJ; Roberts BE
    Immunology; 1990 Jul; 70(3):351-6. PubMed ID: 2143170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use.
    Chang HL; Lefrancois L; Zaroukian MH; Esselman WJ
    J Immunol; 1991 Sep; 147(5):1687-93. PubMed ID: 1831832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CD45RA+ and CD45RA- subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells.
    Okumura M; Fujii Y; Inada K; Nakahara K; Matsuda H
    J Immunol; 1993 Jan; 150(2):429-37. PubMed ID: 7678274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR usage and functional capabilities of human gamma delta T cells at birth.
    Morita CT; Parker CM; Brenner MB; Band H
    J Immunol; 1994 Nov; 153(9):3979-88. PubMed ID: 7930606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
    Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
    J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.